2017-11-08 09:00
Uppsala, Sweden, November 8, 2017. Mattias Bergqvist, VP Clinical Development at Biovica is invited to talk at the 13th Annual Biomarkers Congress 15-16 February 2018, Manchester, UK. As part of the congress Mattias will present at a free webinar on...
2017-11-06 09:00
Uppsala, Sweden, November 6. 2017. The Facebook Group " Aktier – Småbolagsjakten " organizes a live QA session with Biovica International's CEO Anders Rylander on November 20, 2017 between 19.00 - 20.00.
2017-05-22 14:00
Uppsala, Sweden, May 22 2017. Samuel Rotstein has been appointed as Scientific Advisor to Biovica.
2017-05-04 10:00
Uppsala, Sweden, May 4 2017. Biovica has received an order for the company's product DiviTum® from a global contract research company (CRO company), commissioned by a global pharmaceutical company to study the effectiveness of new cancer drugs.
2017-04-11 09:30
Lund University select Biovicas DiviTum® assay for inclusion in a study of 150 women with metastatic breast cancer. The purpose of the study is faster evaluation of treatment efficacy than current standard methods. Lund University will buy about 550...
2017-04-07 09:00
Biovica will participate in a EUROSTAR research project called SUBLYME, that will develop a new targeted drug for blood cancer. For Biovica the project expand the application of DiviTum® to one of the most common forms of blood cancer where the incidence...
2017-04-03 17:30
Uppsala, Sweden, April 3 2017. The latest data of the DiviTum® assay as an efficacy marker of CDK4/6 inhibition was presented in an oral session by Dr. Geoffrey Shapiro, Dana-Farber Cancer Institute, at the 2017 American Association for Cancer Research...
2017-02-22 14:30
Uppsala, Sweden, February 20, 2017. Biovica has strengthened its management team to ensure continued successful development. Cecilia Driving (CFO), Karin Mattsson (R&D Director) and Johanna Faris (Quality and Regulatory Assurance Director) have joined...
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects